<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02571374</url>
  </required_header>
  <id_info>
    <org_study_id>symbioticcolorectalcancer</org_study_id>
    <nct_id>NCT02571374</nct_id>
  </id_info>
  <brief_title>Symbiotics to Prevent Postoperative Infection in Colorectal Cancer</brief_title>
  <official_title>Change in Incidence of Surgical Site Infection After Resection of Colorectal Cancer Between Patients Receiving a Symbiotic Compound and Patients Receiving a Placebo.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blind randomized trial in which patients with colorectal cancer undergoing
      surgery will be selected to receive either a symbiotic formulation or placebo. The
      researchers will compare incidence of surgical site infection between the study groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double blind randomized trial in which patients with colorectal cancer undergoing
      surgery will be randomly selected to receive either a symbiotic formulation or placebo during
      the perioperative period. The researchers will compare incidence of surgical site infection,
      detected by clinical examination and complementary tests (CT scans, X-rays, microbiological
      and hematological tests) between the study groups.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with colorectal cancer on symbiotic to prevent postoperative infection</measure>
    <time_frame>1 month</time_frame>
    <description>This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be selected to receive either a symbiotic formulation or placebo. After we will compare the number of participants with incidence of surgical site infection between the study groups.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>symbiotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Symbiotic group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo group</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>symbiotic group</intervention_name>
    <description>this group received sachets of symbiotic</description>
    <arm_group_label>symbiotic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo group</intervention_name>
    <description>this group received placebo</description>
    <arm_group_label>placebo group</arm_group_label>
    <other_name>maltodextrina</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults between 18 and 85 years old;

          -  Colorectal cancer patients.

          -  Ability to understand and signing the informed consent

        Exclusion Criteria:

          -  Pregnancy (early diagnosis)

          -  Reduced intellectual level that could prevent proper understanding of the objectives
             of the study

          -  Patients with rectal cancer undergoing neoadjuvant treatment (chemotherapy and
             radiotherapy)

          -  Use of products with prebiotic, probiotic and / or symbiotic function or fiber module;
             by more than 3x a week

          -  Refusal to participate and / or to sign the Consent Form Free and Clear
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aline Taborda, ms</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Health Science of Porto Alegre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aline Taborda, ms</last_name>
    <phone>555130849948</phone>
    <email>alinegamarrat@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Damin, dr</last_name>
    <phone>55 51 3359-8000</phone>
    <email>damin@terra.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Clinicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>91770-545</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>aline taborda, ms</last_name>
      <phone>5191065005</phone>
      <email>alinegamarrat@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>October 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2015</study_first_posted>
  <last_update_submitted>October 7, 2015</last_update_submitted>
  <last_update_submitted_qc>October 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Clinicas de Porto Alegre</investigator_affiliation>
    <investigator_full_name>Aline Gamarra Taborda</investigator_full_name>
    <investigator_title>ms</investigator_title>
  </responsible_party>
  <keyword>symbiotic</keyword>
  <keyword>colorectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

